We utilize mechanical dissociation and enzymatic digestion to isolate viable single cells or concentrated protein samples from various tissue types.
Vascular gene & protein expression profiling service at Creative Biolabs helps you obtain high-quality, multidimensional molecular data and validate definitive therapeutic targets through advanced single-cell transcriptomics and high-throughput proteomic arrays. Creative Biolabs provides the essential biological depth and technical precision needed to confirm molecular mechanisms in complex vascular environments.
Vascular development and pathological angiogenesis are governed by a sophisticated interplay of transcriptional regulators and signaling proteins. While bulk analysis often masks critical endothelial signatures, breakthroughs in single-cell RNA sequencing (scRNA-seq) now allow for the identification of organ-specific endothelial subtypes and their distinct metabolic profiles. By comparing gene activity between treated and untreated cells, researchers can identify new drug targets and evaluate treatment-related phenotypic changes at a molecular level. Creative Biolabs leverages these advancements to provide a global view of cellular function and vascular health.
Fig.1 Comparative analysis of gene expression profiles between healthy individuals and patients with CAD.1
Creative Biolabs employs a multi-tiered strategic approach to capture the dynamic molecular landscape of the vasculature, ensuring every profile yields actionable insights.
Empower Your Research with Creative Biolabs — Begin Your Expert Consultation Today
We offer unbiased assessment of transcriptional responses at singular cellular resolution to clarify pathological states and cellular trajectories.
Our simple and economical multiplex assays measure more than 100 proteins in a single sample, eliminating the need for multiple Western blots.
By utilizing proprietary stabilization techniques for tissue recovery, we ensure that delicate RNA and protein signatures remain intact for downstream analysis.
We incorporate machine learning to uncover previously unrecognized gene signatures and optimize biomarker panels for personalized medicine.
We utilize mechanical dissociation and enzymatic digestion to isolate viable single cells or concentrated protein samples from various tissue types.
Techniques such as FACS or immunomagnetic beads are used to enrich for specific vascular cells, such as endothelial cells, while minimizing cellular debris.
Enriched RNA is sequenced using next-generation sequencing (NGS) platforms to achieve absolute quantification and detect novel transcripts.
We perform mass spectrometry (LC-MS/MS) or use antibody-binding arrays to explore protein signaling networks and post-translational modifications.
We integrate molecular profiling with computational fluid dynamic modeling to determine how blood flow-mediated physical forces induce specific transcriptomic alterations and endothelial remodeling.
Our RNA-seq and proteomic techniques can detect rare transcripts and low-abundance signaling molecules even in limited samples, overcoming the limitations of traditional cell volume requirements for analysis.
Our customized solutions are fully applicable to human clinical samples, as well as mouse, rat, and other model organisms, ensuring seamless translational research from bench to bedside.
We offer innovative methods that require no reverse transcription or cDNA library preparation, significantly reducing enzymatic bias in gene measurement to ensure high-fidelity results.
Experience the Creative Biolabs Difference — Contact Us for a Tailored Quote
By comparing gene activity in diseased versus healthy tissues, we can pinpoint dysregulated proteins that serve as potential targets. We then functionalize these findings using proteomic networks to ensure they are truly druggable.
While our antibody arrays are efficient for early discovery of known targets, we also offer untargeted mass spectrometry-based methods that can discover unknown proteins and map post-translational modifications.
This service supports in vivo evaluation of vascular network formation using Matrigel plug assays to examine host cell infiltration, neovascularization, and vessel organization.
Learn More →This service provides quantitative analysis of vascular morphology and radiomic features to identify imaging-derived biomarkers linked to vascular structure and heterogeneity.
Learn More →For detailed project discussions, technical consultations, or to receive a tailored proposal regarding our vascular gene & protein expression profiling service, please reach out to our molecular biology team.
Reference